Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine & Pharmacotherapy 176 (2024) 116860].

Biswas P, Kaium MA, Tareq MMI, Tauhida SJ, Hossain MR, Siam LS, Parvez A, Bibi S, Hasan MH, Rahman MM, Hosen D, Siddiquee MAI, Ahmed N, Sohel M, Azad SA, Alhadrami AH, Kamel M, Alamoudi MK, Hasan MN, Abdel-Daim MM

Open source

DOI: 10.1016/j.biopha.2026.119455
Published: 2026 Jun
Container: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.biopha.2026.119455,
  title = {Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine \& Pharmacotherapy 176 (2024) 116860].},
  author = {Biswas P and Kaium MA and Tareq MMI and Tauhida SJ and Hossain MR and Siam LS and Parvez A and Bibi S and Hasan MH and Rahman MM and Hosen D and Siddiquee MAI and Ahmed N and Sohel M and Azad SA and Alhadrami AH and Kamel M and Alamoudi MK and Hasan MN and Abdel-Daim MM},
  year = {2026},
  journal = {Biomedicine \& pharmacotherapy = Biomedecine \& pharmacotherapie},
  doi = {10.1016/j.biopha.2026.119455},
  url = {https://doi.org/10.1016/j.biopha.2026.119455}
}

RIS

TY  - JOUR
TI  - Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine & Pharmacotherapy 176 (2024) 116860].
AU  - Biswas P
AU  - Kaium MA
AU  - Tareq MMI
AU  - Tauhida SJ
AU  - Hossain MR
AU  - Siam LS
AU  - Parvez A
AU  - Bibi S
AU  - Hasan MH
AU  - Rahman MM
AU  - Hosen D
AU  - Siddiquee MAI
AU  - Ahmed N
AU  - Sohel M
AU  - Azad SA
AU  - Alhadrami AH
AU  - Kamel M
AU  - Alamoudi MK
AU  - Hasan MN
AU  - Abdel-Daim MM
PY  - 2026
JO  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
DO  - 10.1016/j.biopha.2026.119455
UR  - https://doi.org/10.1016/j.biopha.2026.119455
ER  -

APA

P, B., MA, K., MMI, T., SJ, T., MR, H., LS, S., A, P., S, B., MH, H., MM, R., D, H., MAI, S., N, A., M, S., SA, A., AH, A., M, K., MK, A., MN, H., & MM, A. (2026). Retraction notice to "The experimental significance of isorhamnetin as an effective therapeutic option for cancer: A comprehensive analysis" [Biomedicine & Pharmacotherapy 176 (2024) 116860].. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. https://doi.org/10.1016/j.biopha.2026.119455

Source records

pubmed · retrieved 2026-09-25T18:54:21.896Z